Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

11.41
Delayed Data
As of Apr 24
 -0.32 / -2.73%
Today’s Change
10.85
Today|||52-Week Range
18.48
-19.36%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close11.73
Today’s open11.70
Day’s range11.40 - 11.73
Volume1,471,763
Average volume (3 months)1,603,585
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+27.68%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book14.39

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc+0.04+0.21%
SGMOSangamo BioSciences ...-0.84-5.41%
NKTRNektar Therapeutics-0.29-2.62%
BRLIBio-Reference Labora...+0.22+0.63%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Director
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers